PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.
about
The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin.Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumorsRecent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.
P2860
PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@ast
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@en
type
label
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@ast
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@en
prefLabel
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@ast
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues.
@en
P2093
P2860
P356
P1433
P1476
PEGylation, increasing specifi ...... 177Lu-DOTA-bombesin analogues
@en
P2093
Cristina Müller
Dirk A Tourwé
Elisa García Garayoa
Peter Bläuenstein
Simone Däpp
Veronique Maes
P2860
P2888
P356
10.1186/2191-219X-2-24
P577
2012-06-09T00:00:00Z
P5875
P6179
1017502256